Event Date/Time: Feb 24, 2003 End Date/Time: Feb 25, 2003
Report as Spam

Description

Accelerating developments in molecular biology and pharmacology and in chemical and computing technologies are allowing for increasingly efficient production of novel therapeutics. Given the current market for new drugs, this is a trend that needs to continue.
After the success of our 2002 conference, SMi is keen to once again provide the industry with an opportunity to hear about the latest discoveries and developments in drug design technologies and techniques. The conference will include a look at the developments in fragment-based approaches, advances in computational technologies and their implementation, virtual screening, the impact of pharmacogenomics, quality library design, improved ADMET prediction, and hit characterisation, as well as the increasingly multidisciplinary nature of drug design programmes.
You will be given the chance to meet with your peers and exchange ideas that will help carry drug design into the future.

Venue

The Hatton
Hatton Gardens
London
United Kingdom
MORE INFO ON THIS VENUE